
Acculis
AcquiredNew York, United States · Founded 2018 · $5.0M raised
- Headquarters
- New York, New York
- Founded
- 2018
- Business Model
- B2B
- Website
- microsulis.com
- Total Funding
- $5.0M
- Last Round
- $5.0M Corporate RoundJan 2010
- Rounds
- 1
About
Acculis is the microwave tissue ablation product brand of Microsulis Medical Ltd, a UK-based specialist medical device company. The Acculis MTA (Microwave Tissue Ablation) system operates at 2.45 GHz and is used for minimally invasive tumor ablation, particularly for liver tumors. Over 100 Acculis systems have been placed commercially across Europe and globally. The system features a cooled-shaft antenna design for precise, controlled ablation zones.
Summary
Acculis is an Artificial Intelligence company based in New York, United States, founded in 2018. It has raised $5.0M in total across 1 round, most recently a $5.0M Corporate Round round in Jan 2010.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2013
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...

AI compute infrastructure platform backed by NVIDIA.
Cursor is the best way to code with AI, and built to make you extraordinarily productive.

Mistral is on a mission to push AI forward, to serve the open community and their enterprise cust...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...